Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 8Cholangiocarcinoma 7Carcinoma, Hepatocellular 7Liver Neoplasms 5Klatskin Tumor 4Fibrosis 4Neoplasm Metastasis 3Neoplasms 2Liver Diseases 2Hypertension, Portal 2Bile Duct Neoplasms 2Reperfusion Injury 1Rejection, Psychology 1Recurrence 1PRETEXT I Hepatoblastoma 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Colorectal Liver Metastases 1Colonic Neoplasms 1Cholangitis, Sclerosing 1

Interventions

Fluorouracil 218Leucovorin 201Oxaliplatin 191Irinotecan 148Bevacizumab 107Capecitabine 93Cetuximab 89Folfox protocol 54Chemotherapy, Adjuvant 34Panitumumab 30pembrolizumab 23Nivolumab 22Colonoscopy 22Gemcitabine 20Magnetic Resonance Spectroscopy 19Floxuridine 19IFL protocol 18Celecoxib 18Radiotherapy 17Neoadjuvant Therapy 17Early Intervention, Educational 17Drug Therapy 17Laparoscopy 14Cyclophosphamide 14Counseling 14trifluridine tipiracil drug combination 13regorafenib 13XELOX 13Exercise 13Erlotinib Hydrochloride 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Colonic Neoplasms × Liver Transplantation × Clear all
NCT00294827 2023-11-07

Liver Transplantation and Metastatic Colo-rectal Cancer.

Oslo University Hospital

Phase 2 Unknown
25 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡